Biocept Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Strong earthquake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Biocept (BIOC) Misses Q3 EPS by $0.03
November 15, 2021 4:14 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of $0.03, $0.03 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.07 million.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More